GHTF Moscow meeting outcome statement - PDF (143kb)

标准简介

Moscow meeting outcome statement - PDF (143kb)[附网盘链接]是于不久之前发布的GHTF标准,适用于全球。

标准截图

Moscow meeting outcome statement - PDF (143kb)[附网盘链接]
Moscow meeting outcome statement - PDF (143kb)[附网盘链接](截图)

 

标准文档说明

标准文档类型为Moscow meeting outcome statement - PDF (143kb)[附网盘链接]高清PDF版本(文字版),标准文档内可进行搜索,可以复制原文,可粘贴。

标准部分原文

OUTCOME STATEMENT

of the IMDRF-15 MANAGEMENT COMMITTEE

18 to 21 March 2019

The fifteenth meeting of the Management Committee (MC) of the International Medical Device

Regulators Forum (IMDRF) took place in Moscow, Russia, from 18 to 21 March 2019. The

meeting was chaired by Russia. The MC consists of regulators from Australia, Brazil, Canada,

China, the European Union (EU), Japan, Russia, Singapore, South Korea and the United States of

America (USA). Representatives of the World Health Organization (WHO) participated as Official

Observers and the Asian Harmonization Working Party (AHWP), Pan American Health

Organization (PAHO) and Asia-Pacific Economic Cooperation Life Sciences Innovation Forum

Regulatory Harmonization Steering Committee (APEC LSIF RHSC) participated as Regional

Harmonization Initiatives.

th

On Monday, March 18 , IMDRF/DITTA Joint Workshop on “Optimization of Standards for

Regulatory Use” in the frame of IMDRF with about 200 participants has been successfully held.

Industry representatives and the regulators presented their view on the Standards

development, improvements, and guidance. A panel discussion finalized the Workshop.

th

On the first day March 19 , an Open Stakeholder Forum was held. The Forum included

approximately 300 participants representing regulators, industry, and the research community.

In the morning, participants had an opportunity to hear regulatory updates from Australia,

Brazil, Canada, China, EU, Japan, Russia, Singapore, South Korea and the USA and update reports

on IMDRF’s eight current working groups. A Question & Answers Session was held after each

presentation.

The IMDRF’s eight current working groups are:

a. Regulated Product Submission (RPS) - Canada

b. Medical Device Adverse Event Terminology - Japan

c. Good Regulatory Review Practices - USA

d. Standards - USA

e. Personalized Medical Devices-Australia

f. Unique Device Identification - EU

g. Medical device clinical evaluation - China

h. Medical device Cybersecurity – Canada/USA

In the afternoon, there was a Stakeholder session including Official Observers, RHIs and

网盘链接

百度网盘:https://pan.baidu.com/s/1Wrmrrqerd3BgjTLNDt4ldQ
提取码:szbz

【温馨提示】大资料ISO是提供信息发布的专业信息类网站,所有内容均由用户发布,不代表本站观点,本站亦不存储所涉及的文件及资料。如有【免费资料】以及【付费资料】,请用户根据自己的需求,自行判断是否需要获取。如有交易诈骗、内容侵权可发送邮件至kf@dzl100.com,我们审查后若发现情况属实,会立即对相关内容进行删除处理。

加载用时:43.7238 毫秒

相关评论

相关文章